Keval Vasavada
Director, Consulting
Keval Vasavada comes with a right mix of consulting as well as industry experience in pharmaceutical and life sciences.
He holds over 13 years of experience spanning corporate strategy, operations, new process set-up, new product launches, corporate finance, fund raising and commercial deals. Prior to Clarivate, Keval worked with Cipla Pharmaceuticals and IQVIA Consulting.
He has worked on developing disruptive, competitive and sustainable business model for biosimilar business in his previous assignment. He understands the nuances of biopharma manufacturing and has spearheaded commercial discussions with top suppliers of biopharma equipment in the past.
During his consulting stint, he has led projects involving asset portfolio strategy, market entry strategy, commercial due diligence, opportunity assessment for novel therapies in Japan, Asia-Pacific, US, and Europe. He has a rich exposure of working across a breadth of therapeutic areas involving oncology, immunology, neurology, respiratory, rare diseases, and metabolic disorders.
Keval has completed his MBA from the prestigious Indian Institute of Management, Lucknow (India) and did his B.Tech. in Dairy Technology from Dairy Science College, Anand (Gujarat, India).
Latest news
Clarivate Presents Cortellis Regulatory AI Assistant to Cut Through Complexity in Safety and Compliance
Powered by agentic AI, new features help regulatory teams improve accuracy and enable faster, more confident decisions across the product lifecycle London, U.K. — December 4, 2025 — Clarivate Plc…
Clarivate and the Chinese Academy of Sciences Release the 2025 Research Fronts Report
Annual report identifies 110 hot and 18 emerging Research Fronts London, U.K. December 3, 2025. Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, and the Chinese Academy…
Clarivate Reveals Global Shifts in Research Collaboration
New report explores multilateral partnerships, Mainland China’s rising influence, and strategic challenges for the U.S. London, U.K. December 2, 2025: Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence,…
